Two Sigma Advisers’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
Other funds holding ASND
Two Sigma Advisers's ASND Position: Q1 2026 in Review
Two Sigma Advisers sold out of Ascendis Pharma (ASND) in Q1 2026, closing a stake of 47,400 shares — an estimated $10.1M sold.
Two Sigma Advisers first reported a position in ASND in Q1 2024 and held it in 6 quarters. The position peaked at $27.5M in Q2 2024. 278 funds tracked by Wall St. Rank hold ASND as of Q1 2026.
- Two Sigma Advisers reported no remaining Ascendis Pharma position as of Q1 2026 after selling out during the quarter.
- Two Sigma Advisers sold 47,400 Ascendis Pharma shares in Q1 2026, an estimated $10.1M.
- Two Sigma Advisers first reported a position in Ascendis Pharma in Q1 2024 and held it in 6 quarters.
- Two Sigma Advisers's Ascendis Pharma position peaked at $27.5M in Q2 2024.
- 278 funds tracked by Wall St. Rank held Ascendis Pharma as of Q1 2026.
Based on Two Sigma Advisers's 13F filing for Q1 2026.